CLONAZEPAM(CAS: 1622-61-3)

5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (CAS: 1622-61-3) is a crystalline compound with a molecular weight of approximately 300.04 g/mol. It has a high solubility in organic solvents such as methanol and ethanol, but is less soluble in water. The compound is reactive, particularly towards nucleophiles and reducing agents. It can be used in various reactions, including substitution and reduction reactions.

5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (CAS: 1622-61-3) is typically synthesized through the nitration of 2-chlorophenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one. This process involves the use of nitric acid and sulfuric acid as the nitrating mixture. The reaction is conducted under reflux conditions, and the product is isolated and purified through recrystallization.

5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (CAS: 1622-61-3) is utilized in the pharmaceutical industry for its potential medicinal applications. It can also be used in the development of sensors and as an intermediate in the synthesis of other compounds. Its properties make it relevant in the research and development of new materials, particularly in the field of organic electronics.

When handling 5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one (CAS: 1622-61-3), it is crucial to follow proper laboratory safety practices. Always wear appropriate personal protective equipment (PPE) including gloves, goggles, and a lab coat. Handle the compound in a well-ventilated area or a fume hood. In case of a spill, immediately clean up using appropriate methods and ensure proper disposal. Refer to the Material Safety Data Sheet (MSDS) for detailed safety information.